Aij-Lie Kwan Selected Research

Aij-Lie Kwan Research Topics

Disease

36	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 06/2022 - 02/2002
17	Intracranial Vasospasm 06/2022 - 08/2002
16	Neoplasms (Cancer) 05/2021 - 04/2005
10	Inflammation (Inflammations) 06/2022 - 06/2007
8	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 02/2013
6	Brain Injuries (Brain Injury) 06/2022 - 08/2010
6	Brain Neoplasms (Brain Tumor) 04/2017 - 09/2004
5	Burns 01/2020 - 06/2014
4	Stroke (Strokes) 11/2021 - 02/2006
4	Glioma (Gliomas) 10/2021 - 04/2010
4	Glioblastoma (Glioblastoma Multiforme) 05/2021 - 07/2019
4	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2015 - 06/2013
3	Hyperglycemia 06/2022 - 05/2017
3	Infarction (Infarctions) 11/2021 - 11/2004
3	Brain Ischemia (Cerebral Ischemia) 09/2021 - 02/2007
3	Atrophy 01/2020 - 01/2015
3	Hyperalgesia 11/2018 - 08/2011
3	Neuralgia (Stump Neuralgia) 07/2016 - 08/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2010 - 11/2004
2	Carcinogenesis 07/2019 - 04/2017
2	Pain (Aches) 11/2018 - 07/2016
2	Brain Abscess (Abscess, Brain) 01/2014 - 09/2004
2	Paraplegia (Spastic Paraplegia) 01/2014 - 02/2007
2	Necrosis 01/2014 - 01/2013
2	Ischemic Stroke 11/2011 - 11/2004
2	Reperfusion Injury 02/2007 - 11/2004
2	Vascular Remodeling 06/2006 - 11/2004
1	Diabetes Mellitus 06/2022
1	Meningioma (Meningiomas) 01/2021

Drug/Important Bio-Agent (IBA)

14	Endothelin-1 (Endothelin 1)IBA 09/2021 - 08/2002
12	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2010
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2016
7	CGS 26303IBA 07/2016 - 02/2002
7	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2015 - 11/2004
6	Endothelin-Converting EnzymesIBA 03/2007 - 08/2002
5	salicylhydroxamic acid (SHAM)IBA 01/2020 - 06/2006
5	Messenger RNA (mRNA)IBA 06/2015 - 11/2004
5	Endothelins (Endothelin)IBA 06/2006 - 02/2002
4	E-SelectinIBA 01/2015 - 09/2005
3	CytokinesIBA 11/2021 - 08/2010
3	Caspase 3 (Caspase-3)IBA 11/2020 - 07/2019
3	MetalsIBA 01/2018 - 06/2014
3	HMGB1 Protein (HMG1)IBA 02/2016 - 01/2014
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2015 - 03/2007
3	Interleukin-6 (Interleukin 6)IBA 01/2014 - 08/2010
3	Neuroprotective AgentsIBA 03/2009 - 11/2004
3	Peptides (Polypeptides)IBA 06/2006 - 08/2002
2	Therapeutic UsesIBA 06/2022 - 08/2010
2	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2018
2	Phosphotransferases (Kinase)IBA 10/2021 - 01/2014
2	CateninsIBA 05/2021 - 05/2021
2	ImmunosorbentsIBA 01/2021 - 06/2012
2	EnzymesIBA 01/2021 - 06/2012
2	Streptozocin (Streptozotocin)FDA Link 11/2020 - 05/2017
2	CaspasesIBA 11/2020 - 01/2020
2	Erythropoietin FDA Link 01/2020 - 01/2018
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 02/2013
2	Small Interfering RNA (siRNA)IBA 07/2019 - 04/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 04/2017
2	Cyclin D1IBA 07/2019 - 04/2017
2	lithospermate BIBA 10/2015 - 11/2011
2	Glycyrrhizic Acid (Glycyrrhizin)IBA 01/2015 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 06/2014 - 01/2013
2	rho-Associated KinasesIBA 01/2014 - 01/2014
2	Vasoconstrictor AgentsIBA 01/2014 - 10/2006
2	KMUP 1IBA 10/2012 - 08/2012
2	Potassium Channels (Potassium Channel)IBA 10/2012 - 08/2012
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2011 - 08/2010
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2010 - 03/2007
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2009 - 03/2007
2	Monoclonal AntibodiesIBA 06/2007 - 09/2005
2	Neprilysin (Neutral Endopeptidase)IBA 07/2004 - 02/2002
1	Blood Glucose (Blood Sugar)IBA 06/2022
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 06/2022
1	hepatoma-derived growth factorIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	atrial natriuretic factor prohormone (31-67)IBA 09/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2021
1	Temozolomide (Temodar)FDA LinkGeneric 05/2021
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2021
1	triphenyltetrazoliumIBA 01/2021
1	B355252IBA 01/2021
1	(2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oic acid) trifluoroethylamideIBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	bardoxoloneIBA 01/2021
1	fluorocitrateIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Caspase 9IBA 11/2020
1	human AOC3 proteinIBA 04/2020

Therapy/Procedure

5	Therapeutics 09/2021 - 05/2012
4	Radiotherapy 01/2021 - 05/2012
4	Craniotomy 01/2014 - 09/2002
3	Ligation 07/2016 - 08/2011
2	Drug Therapy (Chemotherapy) 04/2017 - 05/2012
2	Denervation 08/2015 - 01/2015
2	Operative Surgical Procedures 02/2014 - 01/2005
2	Decompressive Craniectomy 09/2013 - 06/2013
2	Laminectomy 05/2012 - 04/2005
2	Intravenous Infusions 06/2006 - 11/2004
1	Chemoradiotherapy 05/2021